Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Among patients with type 2 diabetes who have established ASCVD or indicators of high risk, established kidney disease, or heart failure, a sodiumglucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide-1 receptoragonist (GLP-1 RA) with demonstrated cardiovascular disease benefit is recommended (Grade A recommendation)
A diverse diet ensures sufficient micronutrient intake
DPP-4 Inhibitors - Podcast Version DPP-4 inhibitors are oral antidiabetic agents used in the treatment of type 2 diabetes
Haupt E, Ledermann H, Kopcke W
C., Cheiran, G., Rocha, M
US$ 26.93
US$ 20.89
US$ 25.83
US$ 20.86
